Sergei Pechenov

713 total citations
19 papers, 554 citations indexed

About

Sergei Pechenov is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pharmaceutical Science. According to data from OpenAlex, Sergei Pechenov has authored 19 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Pharmaceutical Science. Recurrent topics in Sergei Pechenov's work include Protein purification and stability (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Drug Solubulity and Delivery Systems (4 papers). Sergei Pechenov is often cited by papers focused on Protein purification and stability (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Drug Solubulity and Delivery Systems (4 papers). Sergei Pechenov collaborates with scholars based in United States, Russia and United Kingdom. Sergei Pechenov's co-authors include J. Anand Subramony, Puneet Tyagi, Alexey L. Margolin, Sujit K. Basu, Reena Patel, Chandresh Patel, Jefferson D. Revell, Anton I. Rosenbaum, Letha Chemmalil and Chu W. Jung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Sergei Pechenov

19 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergei Pechenov United States 11 323 178 95 94 69 19 554
Sujit K. Basu United States 8 363 1.1× 97 0.5× 98 1.0× 135 1.4× 35 0.5× 12 617
J.D. Pipkin United States 16 175 0.5× 209 1.2× 34 0.4× 67 0.7× 47 0.7× 34 529
Victoria Sluzky United States 5 486 1.5× 80 0.4× 61 0.6× 65 0.7× 61 0.9× 6 686
Stelios T. Tzannis United States 9 335 1.0× 102 0.6× 69 0.7× 48 0.5× 10 0.1× 9 648
Nicholas G. Lamson United States 11 324 1.0× 177 1.0× 18 0.2× 63 0.7× 20 0.3× 14 657
Mohamed G. Qaddoumi Kuwait 8 155 0.5× 114 0.6× 23 0.2× 37 0.4× 42 0.6× 9 417
Colette Weingarten France 11 283 0.9× 128 0.7× 16 0.2× 73 0.8× 20 0.3× 14 604
Tuo Meng United States 12 233 0.7× 142 0.8× 156 1.6× 33 0.4× 5 0.1× 20 615
Albert J. de Graaf Netherlands 13 352 1.1× 24 0.1× 66 0.7× 42 0.4× 19 0.3× 27 732
Jean‐Marc Grognet France 10 187 0.6× 35 0.2× 30 0.3× 21 0.2× 61 0.9× 24 471

Countries citing papers authored by Sergei Pechenov

Since Specialization
Citations

This map shows the geographic impact of Sergei Pechenov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergei Pechenov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergei Pechenov more than expected).

Fields of papers citing papers by Sergei Pechenov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergei Pechenov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergei Pechenov. The network helps show where Sergei Pechenov may publish in the future.

Co-authorship network of co-authors of Sergei Pechenov

This figure shows the co-authorship network connecting the top 25 collaborators of Sergei Pechenov. A scholar is included among the top collaborators of Sergei Pechenov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergei Pechenov. Sergei Pechenov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tyagi, Puneet, Chandresh Patel, Sergei Pechenov, et al.. (2023). Systems Biology and Peptide Engineering to Overcome Absorption Barriers for Oral Peptide Delivery: Dosage Form Optimization Case Study Preceding Clinical Translation. Pharmaceutics. 15(10). 2436–2436. 6 indexed citations
2.
Tyagi, Puneet, Ruchit Trivedi, Sergei Pechenov, et al.. (2021). Targeted oral peptide delivery using multi-unit particulates: Drug and permeation enhancer layering approach. Journal of Controlled Release. 338. 784–791. 22 indexed citations
3.
Pechenov, Sergei, Jefferson D. Revell, Sarah Will, et al.. (2021). Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease. Scientific Reports. 11(1). 22521–22521. 55 indexed citations
4.
Zhang, Jifeng, et al.. (2018). Submicron Aggregation of Chemically Denatured Monoclonal Antibody. Molecular Pharmaceutics. 15(10). 4710–4721. 13 indexed citations
5.
Tyagi, Puneet, Sergei Pechenov, Jonathan Rios‐Doria, et al.. (2018). Evaluation of Pyrrolobenzodiazepine-Loaded Nanoparticles: A Targeted Drug Delivery Approach. Journal of Pharmaceutical Sciences. 108(4). 1590–1597. 2 indexed citations
6.
Tyagi, Puneet, Sergei Pechenov, & J. Anand Subramony. (2018). Oral peptide delivery: Translational challenges due to physiological effects. Journal of Controlled Release. 287. 167–176. 106 indexed citations
7.
Pechenov, Sergei, Himanshu Bhattacharjee, Dan Yin, Sachin Mittal, & J. Anand Subramony. (2017). Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery. Advanced Drug Delivery Reviews. 112. 106–122. 20 indexed citations
8.
Pechenov, Sergei, et al.. (2017). Metastability Gap in the Phase Diagram of Monoclonal IgG Antibody. Biophysical Journal. 113(8). 1750–1756. 9 indexed citations
9.
Barrett, Stephanie E., Marc Abrams, Rob S. Burke, et al.. (2014). An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agents. International Journal of Pharmaceutics. 466(1-2). 58–67. 13 indexed citations
10.
Govardhan, Chandrika P., Chu W. Jung, Letha Chemmalil, et al.. (2005). Novel Long-Acting Crystal Formulation of Human Growth Hormone. Pharmaceutical Research. 22(9). 1461–1470. 57 indexed citations
11.
Pechenov, Sergei, et al.. (2004). Injectable controlled release formulations incorporating protein crystals. Journal of Controlled Release. 96(1). 149–158. 71 indexed citations
12.
Patel, Reena, et al.. (2003). Crystalline monoclonal antibodies for subcutaneous delivery. Proceedings of the National Academy of Sciences. 100(12). 6934–6939. 131 indexed citations
13.
Pechenov, Sergei, et al.. (2002). Methods for Preparation of Recombinant Cytokine Proteins V. Mutant Analogues of Human Interferon-γ with Higher Stability and Activity. Protein Expression and Purification. 24(2). 173–180. 7 indexed citations
14.
Pechenov, Sergei, et al.. (2002). Recombinant human insulin IX. Investigation of factors, influencing the folding of fusion protein-S-sulfonates, biotechnological precursors of human insulin. Protein Expression and Purification. 26(2). 187–193. 12 indexed citations
15.
Pechenov, Sergei, et al.. (2001). Recombinant Human Insulin. Protein Expression and Purification. 21(1). 176–182. 18 indexed citations
16.
Pechenov, Sergei, et al.. (2001). Methods of Preparation of Recombinant Cytokines: IV. Renaturation of Recombinant Human Interleukin-3. Russian Journal of Bioorganic Chemistry. 27(1). 34–38. 1 indexed citations
17.
Pechenov, Sergei, et al.. (2001). A General Approach to Renaturation of Recombinant Proteins Produced as Inclusion Bodies. Doklady Biochemistry and Biophysics. 380(1-6). 329–331. 4 indexed citations
18.
Pechenov, Sergei, et al.. (1998). Methods of Preparation of Recombinant Cytokine Proteins. Protein Expression and Purification. 14(2). 261–266. 6 indexed citations
19.
Pechenov, Sergei, et al.. (1997). [Preparation of recombinant cytokines. II. Effective method for isolation, purification and renaturation of human recombinant gamma-interferon].. PubMed. 23(9). 721–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sujit K. Basu Breakdown of academic impact, for papers by J.D. Pipkin Breakdown of academic impact, for papers by Victoria Sluzky Breakdown of academic impact, for papers by Stelios T. Tzannis Breakdown of academic impact, for papers by Nicholas G. Lamson Breakdown of academic impact, for papers by Mohamed G. Qaddoumi Breakdown of academic impact, for papers by Colette Weingarten Breakdown of academic impact, for papers by Tuo Meng Breakdown of academic impact, for papers by Albert J. de Graaf Breakdown of academic impact, for papers by Jean‐Marc Grognet
Rankless by CCL
2026